Management of cardiovascular risk in primary prevention: real-world data

被引:0
|
作者
Danchin, N. [1 ]
Puymirat, E. [1 ]
Vedrenne, G. [1 ]
Durand, E. [1 ]
机构
[1] Hop Europeen Georges Pompidou, Dept Cardiol, 20 Rue Leblanc, F-75015 Paris, France
关键词
Primary prevention; Statins; Antihypertensive agents; Tobacco ban; Diabetes; Obesity;
D O I
10.1016/S1878-6480(12)70843-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tremendous progress in the management of cardiovascular risk in the general population has been accomplished over the past two decades, resulting in a decreased incidence of severe cardiovascular conditions such as myocardial infarction, and in a dramatic reduction in cardiovascular mortality. In particular, the management of hypertension and hyperlipidaemia have notably improved. Among public health measures, the smoking ban has been largely successful, while nutritional campaigns and the fight against sedentary behaviours have given mixed results, with continuing growth in the proportion of overweight and obese individuals in the general population. It is therefore essential that recent efforts at prevention are pursued to ensure that the incidence of cardiovascular disease will not rise again in the future. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:279 / 283
页数:5
相关论文
共 50 条
  • [41] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] For insights into the real world, consider real-world data
    Raoof, Sana
    Kurzrock, Razelle
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (673)
  • [43] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [45] Real-World or Controlled Clinical Trial Data in Real-World Practice
    Wu, Ting-Hui
    Yang, James Chih-Hsin
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 470 - 472
  • [46] A FAIR Approach to Real-World Health Data Management and Analysis
    Almeida, Joao Rafael
    Silva, Jorge Miguel
    Oliveira, Jose Luis
    2023 IEEE 36TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, CBMS, 2023, : 892 - 897
  • [47] Need for real-world data on management of the (potentially) failing lead
    Johansen, Jens Brock
    Larsen, Jacob Moesgaard
    Nielsen, Jens Cosedis
    EUROPACE, 2014, 16 (08): : 1105 - 1106
  • [48] Association of pancreatitis with risk of diabetes: analysis of real-world data
    Ba, Djibril M.
    Chinchilli, Vernon M.
    Cozzi, Anna M.
    Bradley, David P.
    Pichardo-Lowden, Ariana R.
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2024, 4
  • [49] Response to: Real-World Data on the Risk of Ventricular Arrhythmias with Sulfonamides
    Islam, Nehal
    Ayele, Henok Tadesse
    Yu, Oriana H. Y.
    Douros, Antonios
    Filion, Kristian B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (02) : 203 - 203
  • [50] Advancements in risk stratification and management strategies in primary cardiovascular prevention
    Barkas, Fotios
    Sener, Yusuf Ziya
    Golforoush, Pelin Arabacilar
    Kheirkhah, Azin
    Rodriguez-Sanchez, Elena
    Novak, Jan
    Apellaniz-Ruiz, Maria
    Akyea, Ralph Kwame
    Bianconi, Vanessa
    Ceasovschih, Alexandr
    Chee, Ying Jie
    Cherska, Mariia
    Chora, Joana Rita
    D'Oria, Mario
    Demikhova, Nadiia
    Burunkaya, Duygu Kocyigit
    Rimbert, Antoine
    Macchi, Chiara
    Rathod, Krishnaraj
    Roth, Lynn
    Sukhorukov, Vasily
    Stoica, Svetlana
    Scicali, Roberto
    Storozhenko, Tatyana
    Uzokov, Jamol
    Lupo, Maria Giovanna
    van der Vorst, Emiel P. C.
    Porsch, Florentina
    ATHEROSCLEROSIS, 2024, 395